Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding
Lab / animal
OA: gold
CC0
AI-generated summary
Prostaglandin E2 increases PAI-1 in normal but not heavy menstrual bleeding endometrial endothelial cells, suggesting a role in regulating fibrinolysis during normal cycles.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To study the role of PGE2 in regulating plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in human primary endometrial endothelial cells (HEECs) from women with normal menstrual bleeding (NMB) and heavy menstrual bleeding (HMB).
DESIGN: In vitro study using endometrial endothelial cells.
SETTING: Research laboratory setting.
PATIENTS: Women with NMB and HMB provided endometrial biopsy samples.
INTERVENTIONS: Prostaglandin E2 and PGE2 receptor-selective agonists were administered to cultured HEECs.
MAIN OUTCOME MEASURES: Levels of PAI-1 and tPA in NMB-HEECs and HMB-HEECs after treatment with PGE2 and receptor-selective agonists.
RESULTS: Prostaglandin E2 increased total PAI-1 levels in NMB-HEECs, but not in HMB-HEECs, which had higher baseline PAI-1 levels. PGE2 receptors (PTGER)1 and PTGER2 agonists increased PAI-1 in NMB-HEECs, whereas PTGER3 and PTGER4 did not. Prostaglandin E2 had no effect on tPA levels in either NMB-HEECs or HMB-HEECs.
CONCLUSIONS: Prostaglandin E2, through PTGER1 and PTGER2, regulates the plasminogen activator system in NMB-HEECs, suggesting a role in reducing fibrinolytic activity during normal menstrual cycles. The lack of PGE2 effect and elevated baseline PAI-1 in HMB-HEECs support using this in vitro model to further understand prostaglandin pathways in NMB and HMB.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (41)
- Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding via openalex
- Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation via openalex
- Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss via openalex
- From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health via openalex
- Heavy menstrual bleeding diagnosis and medical management via openalex
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- Physiology of the Endometrium and Regulation of Menstruation via openalex
- Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea via openalex
- Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding via openalex
- The relationship between menstrual blood loss and prostaglandin production in the human: evidence for increased availability of arachidonic acid in women suffering from menorrhagia via openalex
- W2100085305 via openalex
- W2107053633 via openalex
- W2107648329 via openalex
- W2118819264 via openalex
- W2155438634 via openalex
- W2155624681 via openalex
- W2436137723 via openalex
- W2793983845 via openalex
- W2803278784 via openalex
- W3021782623 via openalex
- W3134763901 via openalex
- W4200271992 via openalex
- W4236187855 via openalex
- W4283076612 via openalex
- W4297489562 via openalex
- W4317930374 via openalex
- W6608163374 via openalex
- W6675487962 via openalex
- W202129753 via openalex
- W6680187749 via openalex
- W1608726413 via openalex
- W1970924690 via openalex
- W1984195795 via openalex
- W2011625567 via openalex
- W2014498182 via openalex
- W2046175900 via openalex
- W2047661631 via openalex
- W2060130072 via openalex
- W2085864430 via openalex
- W2096072209 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:45:04.264734+00:00
License: CC0
· commercial use OK